期刊文献+

比伐卢定对代谢综合征急性ST段抬高心肌梗死患者急诊经皮冠状动脉介入治疗的安全性 预览

Safety of bivalirudin in primary percutaneous coronary intervention on patients with acute ST-segment elevation myocardial Infarction and metabolic syndrome
在线阅读 免费下载
收藏 分享 导出
摘要 目的观察比伐卢定对代谢综合征急性ST段抬高心肌梗死(STEMT)患者急诊经皮冠状动脉介入治疗(PCI)的安全性。方法纳入2016年7月至2017年7月代谢综合征STEMT患者92例,根据术中用药情况分为比伐卢定组和肝素组,其中比伐卢定组42例,肝素组50例。记录患者围手术期及术后1年出血事件及心血管不良事件。结果两组主要心血管不良事件发生率无统计学差异(P>0.05),比伐卢定组出血事件发生率低于肝素组(P<0.05)。结论对于代谢综合征STEMT患者应用比伐卢定具有良好的安全性,且与肝素相比具有较低的出血发生率。 Objective To observe Safety of bivalirudin in primary percutaneous coronary intervention (P CI) on patients with acute ST-segment elevation myocardial Infarction( STEMI) and metabolic syndrome. Methods From 2016/7 to 2017/7,a total of 92 patients with acute STEMI and metabolic syndrome treated by primary PCI in our hospital were retrospectively studied.The patients were divided in to two groups according to procedural bivalirudin application as bivalirudin group and heparin group. The baseline condition,coronary artery imaging condition,perioperative and 30-day post-operative occurrence of bleeding events and adverse cardiovascular events were compared between two groups. Results There was no significant difference in incidence of adverse cardiovascular events between two groups( P < 0.05),but the total number of cases with occurrence of bleeding events in the bivalirudin group were significant lower than the heparin group. Conclusion With advantage of lower incidence of bleeding and better safety,bivalirudin shows equivalent antithrombotic effect to heparin.
作者 孙小强 张善春 邢晓春 李广阔 何峰 田凤石 SUN Xiaoqiang;ZHANG Shanchun;XING Xiaochun;LI Guangkuo;HE Feng;TIAN Fengshi(The Fourth Central Hospital of Tianjin,Tianjin 300140,China)
出处 《实用医学杂志》 CAS 北大核心 2019年第9期1473-1476,共4页 The Journal of Practical Medicine
基金 天津市科技计划项目(编号:17ZXMFSY00200).
关键词 代谢综合征 急性ST段抬高心肌梗死 经皮冠状动脉介入治疗 比伐卢定 metabolic syndrome ST-segment elevation myocardial Infarction percutaneous coronary intervention bivalirudin
作者简介 通信作者:田凤石,E-mail:28963196@qq.com.
  • 相关文献

参考文献4

二级参考文献129

  • 1重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:31
  • 2JaffeAS.Third universal definition of myocardial infarction[J]. Clin Biochem, 2013, 46(1-2): 1-4. 被引量:1
  • 3WhiteHD, ThygesenK, AlpertJS, et al.Clinical implications of the third universal definition of myocardial infarction[J]. Heart, 2014, 100(5): 424-432. 被引量:1
  • 4StegPG, JamesSK, AtarD, et al.ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Eur Heart J, 2012, 33(20): 2569-2619. 被引量:1
  • 5O'GaraPT, KushnerFG, AscheimDD, et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2013, 127(4): e362-e425. 被引量:1
  • 6WindeckerS, KolhP, AlfonsoF, et al.2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)[J]. Eur Heart J, 2014, 35(37): 2541-2619. 被引量:1
  • 7Van de WerfF, BaxJ, BetriuA, et al.Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology[J]. Eur Heart J, 2008, 29(23): 2909-2945. 被引量:1
  • 8TerkelsenCJ, S?rensenJT, MaengM, et al.System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention[J]. JAMA, 2010, 304(7): 763-771. 被引量:1
  • 9Le MayMR, SoDY, DionneR, et al.A citywide protocol for primary PCI in ST-segment elevation myocardial infarction[J]. N Engl J Med, 2008, 358(3): 231-240. 被引量:1
  • 10BeckerL, LarsenMP, EisenbergMS.Incidence of cardiac arrest during self-transport for chest pain[J]. Ann Emerg Med, 1996, 28(6): 612-616. 被引量:1

共引文献1045

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈